Brief: BioInvent Q4 Sales SEK 3 Million

BioInvent International AB

26/02/2026 07:00

Feb 26 (Reuters) - BioInvent Q4 net income SEK -125.8 million.

Q4 adjusted EPS SEK -1.91

Q4 adjusted free cash flow SEK -90.6 million